Answers are grounded in this paper and cite their sources.
This analysis demonstrates the effectiveness of iron therapy in improving outcomes for patients on hemodialysis, implying enhanced management of anemia.
Anemia is very common in patients undergoing hemodialysis. The main cause is iron deficiency anemia. Erythropoietin deficiency is another major cause of anemia. Maintaining sufficient iron stores while using the lowest epoetin dose is the main therapeutic goal in hemodialysis patients to avoid the side effects of epoetin.
No takes yet. Share an insight, caveat, or question.
Alomi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: